CRSA
Crescent Acquisition Corp. [CRSA] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CRSA Stock Summary
In the News
CRSA Financial details
Company Rating
Neutral
Market Cap
817.65M
Income
-68.79M
Revenue
28.91M
Book val./share
4.63
Cash/share
5.17
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
24 May 2021
P/E
-110.5
Forward P/E
-
PEG
0.42
P/S
-
P/B
1.13
P/C
1.7
P/FCF
-527.57
Quick Ratio
0.12
Current Ratio
0.14
Debt / Equity
0.04
LT Debt / Equity
0.01
-
-
EPS (TTM)
-2.21
EPS next Y
-
EPS next Q
-
EPS this Y
-190.57%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-1315%
-
-
-
-
SMA20
-
SMA50
50%
SMA100
-
Inst Own
63.48%
Inst Trans
0.84%
ROA
-1%
ROE
-1%
ROC
-0.01%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
8.733-9.1663
52W High
-2.11%
52W Low
+10.13%
RSI
45
Rel Volume
0.57
Avg Volume
381.66K
Volume
216.45K
Perf Week
221.53%
Perf Month
233.71%
Perf Quarter
-
Perf Half Y
0%
-
-
-
-
Beta
0.0799
-
-
Volatility
2.16%, 1.1%
Prev Close
228.73%
Price
8.81
Change
220.36%
CRSA Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2020-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 |
|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0 | 0 | 0 | |
| Net income per share | 0 | 0.09 | -0.08 | |
| Operating cash flow per share | -0.01 | -0.04 | -0.05 | |
| Free cash flow per share | -0.01 | -0.04 | -0.05 | |
| Cash per share | 0 | 0.04 | 0.01 | |
| Book value per share | 0 | 7.84 | 7.76 | |
| Tangible book value per share | 0 | 7.84 | 7.76 | |
| Share holders equity per share | 0 | 7.84 | 7.76 | |
| Interest debt per share | 0.01 | 0 | 0 | |
| Market cap | 303.13M | 312.5M | 326.56M | |
| Enterprise value | 303.34M | 311.37M | 326.26M | |
| P/E ratio | -45.78K | 113.63 | -131.07 | |
| Price to sales ratio | 0 | 0 | 0 | |
| POCF ratio | -1.63K | -248.91 | -210.7 | |
| PFCF ratio | -1.63K | -248.91 | -210.7 | |
| P/B Ratio | 17.44K | 1.27 | 1.35 | |
| PTB ratio | 17.44K | 1.27 | 1.35 | |
| EV to sales | 0 | 0 | 0 | |
| Enterprise value over EBITDA | -45.82K | 78.91 | -138.55 | |
| EV to operating cash flow | -1.63K | -248.01 | -210.51 | |
| EV to free cash flow | -1.63K | -248.01 | -210.51 | |
| Earnings yield | 0 | 0.01 | -0.01 | |
| Free cash flow yield | 0 | 0 | 0 | |
| Debt to equity | 15.13 | 0 | 0 | |
| Debt to assets | 0.5 | 0 | 0 | |
| Net debt to EBITDA | -32.92 | -0.29 | 0.13 | |
| Current ratio | 0.09 | 1.31 | 0.14 | |
| Interest coverage | 0 | 0 | 0 | |
| Income quality | 28.05 | -0.46 | 0.62 | |
| Dividend Yield | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | |
| Graham number | 0 | 3.94 | 3.73 | |
| ROIC | -0.02 | 0 | -0.01 | |
| Return on tangible assets | -0.01 | 0.01 | -0.01 | |
| Graham Net | -0.01 | -0.27 | -0.35 | |
| Working capital | -460.73K | 295K | -2.26M | |
| Tangible asset value | 17.38K | 245.11M | 242.62M | |
| Net current asset value | -460.73K | -8.46M | -11.01M | |
| Invested capital | 15.13 | 0 | 0 | |
| Average receivables | 0 | 0 | 0 | |
| Average payables | 0 | 163.2K | 1.47M | |
| Average inventory | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 0 | |
| Days payables outstanding | 0 | 0 | 0 | |
| Days of inventory on hand | 0 | 0 | 0 | |
| Receivables turnover | 0 | 0 | 0 | |
| Payables turnover | 0 | 0 | 0 | |
| Inventory turnover | 0 | 0 | 0 | |
| ROE | -0.38 | 0.01 | -0.01 | |
| Capex per share | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2021-06-30 for Q2
| Metric | History | 2018-03-31 | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2021-06-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0 | 0 | 0 | 0 | 0.93 | |
| Net income per share | 0 | 0.01 | 0.02 | 0.2 | -2.43 | |
| Operating cash flow per share | 0 | 0.01 | -0.01 | -0.08 | -0.31 | |
| Free cash flow per share | 0 | 0.01 | -0.01 | -0.08 | -0.33 | |
| Cash per share | 0 | 0.07 | 0.03 | 0.01 | 5.17 | |
| Book value per share | 0 | 7.76 | 7.86 | 6.74 | 4.63 | |
| Tangible book value per share | 0 | 7.76 | 7.86 | 6.74 | 2.4 | |
| Share holders equity per share | 0 | 7.76 | 7.86 | 6.74 | 4.63 | |
| Interest debt per share | 0 | 0.01 | 0 | 0 | 0.15 | |
| Market cap | 303.13M | 303.13M | 307.81M | 314.32M | 275.31M | |
| Enterprise value | 0 | 301.38M | 306.95M | 315.82M | 119.42M | |
| P/E ratio | -48.58K | 442.22 | 158.53 | 12.28 | -0.91 | |
| Price to sales ratio | 0 | 0 | 0 | 0 | 9.52 | |
| POCF ratio | -4.16K | 1.27K | -785.1 | -126.54 | -28.53 | |
| PFCF ratio | -4.16K | 1.27K | -785.1 | -126.54 | -26.85 | |
| P/B Ratio | 0 | 1.25 | 1.25 | 1.49 | 1.9 | |
| PTB ratio | 0 | 1.25 | 1.25 | 1.49 | 1.9 | |
| EV to sales | 0 | 0 | 0 | 0 | 4.13 | |
| Enterprise value over EBITDA | 0 | 1.39K | 435.51 | 49.35 | -1.58 | |
| EV to operating cash flow | 0 | 1.26K | -782.9 | -127.14 | -12.38 | |
| EV to free cash flow | 0 | 1.26K | -782.9 | -127.14 | -11.65 | |
| Earnings yield | 0 | 0 | 0 | 0.02 | -0.28 | |
| Free cash flow yield | 0 | 0 | 0 | -0.01 | -0.04 | |
| Debt to equity | 0 | 0 | 0 | 0 | 0.04 | |
| Debt to assets | 0 | 0 | 0 | 0 | 0.02 | |
| Net debt to EBITDA | 0 | -8.04 | -1.22 | 0.23 | 2.06 | |
| Current ratio | 0 | 2.01 | 1.17 | 0.11 | 2.93 | |
| Interest coverage | 0 | 0 | 0 | 0 | 79.91 | |
| Income quality | 46.7 | 1.4 | -0.81 | -0.39 | 0.13 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0.85 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 1.04 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0.26 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0.06 | |
| Capex to revenue | 0 | 0 | 0 | 0 | -0.02 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | -0.63 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0.01 | |
| Graham number | 0 | 0.98 | 1.66 | 5.57 | 15.91 | |
| ROIC | 0 | 0 | 0 | 0 | -0.5 | |
| Return on tangible assets | 0 | 0 | 0 | 0.03 | -0.38 | |
| Graham Net | 0 | -0.25 | -0.28 | -1.37 | 1.6 | |
| Working capital | 0 | 1.11M | 146.49K | -2.76M | 121.48M | |
| Tangible asset value | 0 | 242.36M | 245.6M | 210.7M | 74.91M | |
| Net current asset value | 0 | -7.64M | -8.6M | -42.77M | 61.02M | |
| Invested capital | 0 | 0 | 0 | 0 | 0.04 | |
| Average receivables | 0 | 0 | 0 | 0 | 7.93M | |
| Average payables | 0 | 0 | 0 | 0 | 2.33M | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 49.34 | |
| Days payables outstanding | 0 | 0 | 0 | 0 | 16.29 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 1.82 | |
| Payables turnover | 0 | 0 | 0 | 0 | 5.53 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | 0 | 0 | 0 | 0.03 | -0.52 | |
| Capex per share | 0 | 0 | 0 | 0 | -0.02 |
CRSA Frequently Asked Questions
What is Crescent Acquisition Corp. stock symbol ?
Crescent Acquisition Corp. is a US stock , located in Los angeles of California and trading under the symbol CRSA
What is Crescent Acquisition Corp. stock quote today ?
Crescent Acquisition Corp. stock price is $8.81 today.
Is Crescent Acquisition Corp. stock public?
Yes, Crescent Acquisition Corp. is a publicly traded company.
Company Profile
- Volume Average 381.66K
- Market Capitalization 817.65M
- CEO Mr. Todd M. Purdy
- Headquarters Los Angeles,CALIFORNIA,US
- IPO Date 2019-03-08
-
Website
http://www.crescentspac.com 
Crescent Acquisition Corp. intends to acquire assets and businesses through a merger, capital stock exchange, stock purchase, reorganization, or business combination. The company was formerly known as Crescent Funding Inc. and changed its name to Crescent Acquisition Corp. in October 2018. The company was founded in 2017 and is based in Los Angeles, California.
